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Previous studies from the Congenital Heart SurgeonsSociety (CHSS) have examined in detail risk factors
and survival patterns in patients with aortic atresia, in
patients with interrupted aortic arch,1,2 and in patients
with coarctation of the aorta. All of these diseases are
characterized by significant obstruction to left ventricu-
lar outflow, significant interference with systemic arte-
rial perfusion, or both. In addition to these patients,
there exists a complex group of patients without aortic
atresia but with critical left ventricular outflow obstruc-
tion, with patency of the aortic valve and either sys-
temic arterial flow depending on patency of the ductus
arteriosus or with markedly depressed left ventricular
function at presentation. 
Considerable anatomic and morphologic variability
exists within this patient collection. Aortic valves may
be morphologically normal but miniature, anatomical-
ly small and dysplastic, or of adequate size for the
patient’s body surface area but morphologically dys-
plastic and stenotic. Any of these scenarios may result
Objectives: We sought to determine factors that would predict whether a
biventricular repair or Norwood procedure pathway would give the best sur-
vival in neonates with critical aortic stenosis. 
Methods: Survival and risk factors were determined with parametric time-
dependent event analysis for patients undergoing either the Norwood proce-
dure or biventricular repair, and predicted optimal pathway and survival ben-
efit were derived from multivariable linear regression.
Results: From 1994 to 2000, 320 neonates with critical left ventricular out-
flow obstruction were entered into a prospective multi-institutional study.
Patients who died without intervention (n = 19) and those with primary car-
diac transplantation (n = 6) were excluded. An initial intended biventricular
repair pathway was indicated in 116 patients, with survival of 70% at 5
years. An initial Norwood procedure was performed in 179 patients, with
survival of 60% at 5 years. Using predictions from separate multivariable
hazard models for survival with each of the 2 pathways, we determined pre-
dicted optimal pathway and survival benefit for each patient. Significant
independent factors associated with greater survival benefit for the Norwood
procedure versus biventricular repair included younger age at entry, lower 
z-score of the aortic valve and left ventricular length, higher grade of endo-
cardial fibroelastosis, absence of important tricuspid regurgitation, and larg-
er ascending aorta. Predicted survival benefit favored the Norwood proce-
dure in 50% of patients who had biventricular repair, and it favored
biventricular repair in 20% of patients who had the Norwood procedure.
Conclusions: Morphologic and functional factors can be used to predict opti-
mal pathway and survival benefit in neonates with critical left ventricular
outflow obstruction. (J Thorac Cardiovasc Surg 2001;121:10-27)
Gary K. Lofland, MDa
Brian W. McCrindle, MDb
William G. Williams, MDc
Eugene H. Blackstone, MDd
Christo I. Tchervenkov, MDe
Rekwan Sittiwangkul, MDb
Richard A. Jonas, MDf
Congenital Heart Surgeons Society
CRITICAL AORTIC STENOSIS IN THE NEONATE: A MULTI-INSTITUTIONAL STUDY OF MANAGEMENT,
OUTCOMES, AND RISK FACTORS
From the Section of Cardiac Surgery,a Children’s Mercy Hospital,
Kansas City, Mo; Division of Cardiology,b The Hospital for Sick
Children, Toronto, Ontario, Canada; Division of Cardiovascular
Surgery,c The Hospital for Sick Children, Toronto, Ontario,
Canada; Department of Thoracic and Cardiovascular Surgery,d
Cleveland Clinical Foundation, Cleveland, Ohio; Division of
Cardiovascular Surgery,e Montreal Children’s Hospital,
Montreal, Quebec, Canada; and Department of Cardiac Surgery,f
The Children’s Hospital, Boston, Mass.
Financial support for this project and the Congenital Heart Surgeons
Society Data Center is provided by the members of the Society
and by a grant from the Hospital for Sick Children, Toronto,
Ontario, Canada.
Read at the Eightieth Annual Meeting of The American Association
for Thoracic Surgery, Toronto, Ontario, Canada, April 30–May 3,
2000.
Received for publication May 4, 2000; revisions requested June 22,
2000; revisions received Aug 17, 2000; accepted for publication
Aug 25, 2000.
Address for reprints: Gary K. Lofland, MD, Section of Cardiac
Surgery, The Children’s Mercy Hospital, 2401 Gillham Rd,
Kansas City, MO 64108 (E-mail: glofland@cmh.edu).
Copyright © 2001 by The American Association for Thoracic Surgery
0022-5223/2001 $35.00 + 0 12/6/111207
doi:10.1067/mtc.2001.111207
10
The Journal of Thoracic and
Cardiovascular Surgery
Volume 121, Number 1
Lofland et al 11
in severe left ventricular outflow tract obstruction or
critical aortic stenosis. 
Of equal importance in this patient population is the
status of the mitral valve. The mitral valve may be small
but morphologically normal or dysplastic and stenotic.
Other considerations include adequacy of left ven-
tricular size and function, presence of an atrial septal
defect, presence of a ventricular septal defect, and pres-
ence of coarctation of the aorta.
Patients with critical aortic stenosis have a wide
range of therapeutic options, allowing for considerable
controversy in their management. Decision-making is
further complicated by the need to rapidly decide on a
course of therapy. In the absence of specific therapy,
closure of the ductus arteriosus results in death from
congestive heart failure, systemic hypoperfusion, or
coronary insufficiency. 
A study of outcomes in a large group of neonates
with left ventricular outflow tract abnormalities result-
ing in critical aortic stenosis could be of value in the
care of these critically ill neonates. A multi-institution-
al study was undertaken to determine the management
and outcomes of these patients and to identify risk fac-
tors for early survival. 
We sought to determine the demographic, functional,
and morphologic factors that would predict whether a
biventricular repair or Norwood single-ventricle pallia-
tion pathway would give the best survival in neonates
with critical left ventricular outflow obstruction.
Patients and methods
Between January 1994 and February 2000, 320 neonates
(aged < 30 days) with critical aortic stenosis (critical left ven-
tricular outflow tract obstruction) were entered into a prospec-
tive study. Twenty-four institutions contributed patients to this
study. Participation in this project and submission of patient
information were voluntary and confidential. To the best of our
knowledge, these case totals represent all of the patients pre-
senting to each of the institutes participating in this study. All
patients meeting entry criteria were enrolled. 
Study population. Patients were eligible for entry into the
study if they were admitted to a participating CHSS institu-
tion, had the appropriate cardiac diagnosis, and were selected
for a procedure addressed at the left ventricular outflow
obstruction (including cardiac transplantation) within 30 days
of birth. All consecutive patients were prospectively entered
into the study between January 1994 and February 2000.
Critical left ventricular outflow obstruction was defined as
the presence of moderately or severely reduced left ventricu-
lar function at entry (time of initial admission to CHSS insti-
tution) or the presence of systemic perfusion dependent on
right ventricular output via a patent arterial duct. All patients
had to have important left ventricular outflow obstruction or
hypoplasia with concordant atrioventricular and ventriculoar-
terial connections, with echocardiographic, angiographic, or
surgical demonstration of patency of the aortic valve. Patients
with large ventricular septal defects or associated cardiac
anomalies judged to be of worse prognostic significance than
their left ventricular obstructive lesions were excluded.
Data collection. Investigators were requested to submit
copies of medical records, including imaging reports, proce-
dure reports, and hospital discharge summaries. Records of
subsequent clinical assessments, hospital admissions, and
procedures were also submitted. In addition, the physician,
family, or guardian of each patient not known to have died
was contacted each year since the beginning of the study, and
vital status and intervening problems and procedures were
ascertained. The most recent follow-up for patients enrolled
in the earlier years of the study was conducted between May
and September 1999. Follow-up was 100% complete with no
patients being lost to follow-up. As this is an ongoing study,
enrollment of patients continues. For purposes of statistical
analysis, only patients enrolled before February 2000 were
included. Patients enrolled after February 2000 will be
included in subsequent studies. Confidentiality of patient
information was maintained.
Cardiac function and morphology. Quantitative and qual-
itative data of cardiac structure and function were abstracted
from reports of echocardiograms, angiograms, operations, and
autopsies to confirm patient eligibility. Functional and mor-
phologic predictors of outcomes were derived from the initial
echocardiogram performed at presentation, and data were
abstracted. The format for echocardiographic data tabulation
is illustrated in Appendix A. Given variability in the standard-
ization and comprehensiveness of submitted echocardio-
graphic reports, we defined an echocardiographic measure-
ment protocol for multiple left heart obstructive or hypoplastic
lesions. Initial (before any important intervention) echocar-
diogram videotape recordings were requested from contribut-
ing institutions. The submitted recordings were then reviewed
and standardized measurements made by a single experienced
pediatric echocardiographer blinded to subsequent manage-
ment and outcome of the patient. From an initial study popu-
lation of 323 neonates, 214 initial echocardiogram recordings
were received and underwent independent review. From the
review, 3 patients were identified and excluded from further
analysis due to demonstrated lack of patency of the aortic
valve (aortic atresia). Data were abstracted from detailed
echocardiography reports regarding an additional 40 patients
for whom a recording was not submitted for review. For the
remaining patients, functional and morphologic data were
abstracted from reports of cardiac catheterization, surgery, and
autopsy. Echocardiographic morphologic measurements were
standardized to body surface area as z-scores on the basis of
published normative data.3 Dimensions were also normalized
by indexing to body surface area.
Management. All initial and subsequent procedures were
noted. On the basis of the first procedure performed to
address the left ventricular outflow obstruction, patients were
grouped according to their initial designation by their institu-
tion as being on either a 2-ventricle or biventricular repair
pathway or a single-ventricle palliation or primary cardiac
transplantation pathway. Initial biventricular repair proce-
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dures included transcatheter balloon and surgical aortic
valvotomy, primary aortic valve replacement, and the Yasui
procedure (aortopulmonary anastomosis with Rastelli con-
nection). Single-ventricle palliation consisted of the
Norwood procedure and its modifications. Subsequent proce-
dures, especially those related to left ventricular outflow
obstruction, were also noted. In patients who crossed over to
the alternate pathway after an initial procedure, the intended
initial strategy was considered to have failed. 
Data analysis. The goal of the analysis was directed to opti-
mizing the initial decision for biventricular or non-biventricu-
lar repair pathway. All analyses were performed with SAS sta-
tistical software, version 7 (SAS Institute, Inc, Cary, NC).
Data are described as frequencies, medians with ranges, and
means with standard deviations as appropriate. In the case of
missing data, the number of non-missing values is given for
descriptive analyses. In all multivariable analyses, missing
values for variables, particularly echocardiographic measure-
ments, were managed as follows: In cases in which patient
weight, height, or body surface area was not reported for the
time of the echocardiogram report or recording, informative
imputation was based on available patient characteristics
using standard percentile growth charts, with the assumption
that the patient’s height and weight percentile would be con-
cordant. A general missing value indicator variable was creat-
ed for missing echocardiogram-recording review, and then the
mean value of available information was substituted for miss-
ing values (noninformative imputation). In all multivariable
analyses, the relevant missing value indicator variables were
carried to adjust for the possibility that patients with a given
value missing may be different in terms of characteristics or
risk from those in whom the value is not missing.
Table I. Selected patient characteristics
Initial intended pathway
Biventricular repair (n = 116) Norwood procedure (n = 179) P value
Variable n m Value n m Value
Median (range) age at entry (d) 116 0 2 (0-29) 179 0 1 (0-30) <.015
Sex, female/male 116 0 15:101 178 1 60:118 <.001
Associated cardiac anomalies 116 0 7 (6%) 179 0 11 (6%) .97
Persistent left SVC 116 0 4 (3%) 179 0 12 (7%) .30
Genetic or anomaly syndrome 116 0 2 (2%) 179 0 7 (4%) .50
Noncardiac anomaly 116 0 5 (4%) 179 0 11 (6%) .61
Morphology and function
Echocardiogram independently reviewed 116 0 82 (71%) 179 0 116 (65%) .30
Mean (SD) z-score:
Tricuspid valve diameter 83 33 –1.38 (2.26) 119 60 –0.83 (2.17) .09
Mitral valve diameter (4-chamber view) 86 30 –2.22 (2.82) 121 58 –6.38 (2.91) <.001
Mitral valve diameter (long-axis view) 82 34 –1.20 (1.99) 118 61 –5.33 (2.70) <.001
LV endocardial length (4-chamber view) 83 33 –0.84 (2.26) 112 67 –5.63 (3.23) <.001
Aortic valve anulus (long-axis view) 101 15 –3.69 (2.40) 146 33 –8.25 (3.75) <.001
Aortic valve at sinuses (long-axis view) 83 33 –2.51 (2.30) 119 60 –6.28 (3.50) <.001
Aorta at sinotubular junction 81 35 –0.41 (2.25) 116 63 –4.44 (3.33) <.001
(long-axis view)
ASD 94 22 16 (17%) 136 43 47 (35%) .004
Mean (SD) ratio of RA/LA area 80 36 0.93 (0.34) 110 69 1.29 (0.51) <.001
VSD 93 23 7 (8%) 133 46 31 (23%) .002
Moderate or large VSD 93 23 5 (5%) 133 46 25 (19%) .004
Moderate or severe tricuspid regurgitation 90 26 6 (7%) 129 50 10 (8%) .77
Mean (SD) ratio of mitral valve 74 42 0.45 (0.09) 107 72 0.26 (0.10) <.001
area to total AV valve area
Moderate or severe mitral regurgiation 101 15 9 (9%) 126 53 3 (2%) .037
Moderate or severe mitral stenosis 93 23 1 (1%) 130 49 20 (16%) <.001
Parachute mitral valve 90 26 2 (2%) 123 56 13 (11%) .03
Grade of endocardial fibroelastosis 90 26 119 60
None 47 (52%) 59 (50%) .54
Mitral valve papillary muscles only 34 (38%) 42 (35%)
+ Some endocardial involvement 7 (8%) 17 (14%)
+ Extensive endocardial involvement 2 (2%) 1 (1%)
Mean (SD) LV ejection fraction (%) 76 40 39 (17) 105 74 41 (17) .52
Moderate or severe subaortic obstruction 99 17 6 (6%) 119 60 26 (22%) .001
Mean (SD) ascending aorta diameter (mm) 88 28 8.1 (2.2) 147 32 5.6 (1.8) <.001
Presence of aortic coarctation 104 12 11 (11%) 133 46 41 (31%) <.001
ASD, Atrial septal defect; AV, atrioventricular; LV, left ventricular; m, number of missing values; n, number of non-missing values; RA/LA, right atrial/left atrial; SD,
standard deviation; SVC, superior vena cava; VSD, ventricular septal defect. 
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Factors associated with initial intended strategy. The
management pathways of all patients were determined and
described, including unintended crossover to alternative path-
ways. Patients who died before any procedure to address left
ventricular outflow obstruction could be performed (n = 19)
were excluded from further analysis. Independent demo-
graphic, functional, and morphologic factors associated with
the initial intention for a biventricular versus a non-biventric-
ular repair pathway were sought in multivariable logistic
regression using the variables noted in Table I and Appendix
A. For this analysis, ordinal and continuous variables were
examined by decile analysis to determine possible transfor-
mations of scale needed to match the scale of the variable
with the scale of the risk (calibration). Variables were
screened by examining frequency tables, and those associat-
ed with 5 or fewer deaths were eliminated from consideration
because of the risk of model overdetermination. Variables
were entered into the model in a semidirected manner, with
Fig 1. Subsequent procedures and mortality for patients who had an initial procedure indicating an intended non-
biventricular repair pathway or who died without having had a procedure to address the left ventricular outflow
obstruction. BVR, Biventricular repair; CPC, cavopulmonary connection; HTx, heart transplantation; Yasui, cre-
ation of a Damus-Kaye-Stansel type connection with closure of a ventricular septal defect to incorporate the
neoaorta to the left ventricle and a Rastelli-type connection from the right ventricle to the pulmonary arteries.
Fig 2. Subsequent procedures and mortality for patients who had an initial transcatheter balloon aortic valvotomy
to address the left ventricular outflow obstruction. AVR, Aortic valve replacement; BAV, balloon aortic valvotomy;
Fon, Fontan procedure; HTx, heart transplantation; Nor, Norwood procedure; SAV, surgical aortic valvotomy.
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initial selection criteria for variable entry set at the P ≤ .15
level of significance. Interaction terms were examined for
additional entry into the final multivariable model.
Factors associated with time-related death. All-cause
mortality was considered in this analysis. Non–risk-adjusted
nonparametric estimates of time-related death were plotted as
Kaplan-Meier estimates. Parametric estimates were obtained
by modeling the hazard function, searching for multiple phas-
es of risk and the characteristic equation of each phase.4 This
analysis was initially performed for the entire study popula-
tion and then separately for patients who had initial biventric-
ular repair strategy and those who had an initial Norwood pro-
cedure. Patients who had primary cardiac transplantation (n =
6) were excluded from this analysis due to small numbers and
elimination of morphologic predictors. In this study, for all 3
analyses only a single early hazard phase was noted, so a sin-
gle stream of concomitant variables was analyzed. The multi-
variable analysis was performed in a manner similar to that
used for the multiple logistic regression analysis described
above, with the same strategy for variable selection and reten-
tion in the models. Incremental risk factors for time-related
deaths were determined separately for patients on an initial
biventricular versus a Norwood procedure intention-to-treat
pathway. The parameter estimates from the separate multi-
variable equations were then used in the subsequent analysis.
Prediction of survival benefit and optimal pathway.
The optimal pathway and magnitude of survival benefit at
5 years after study entry were predicted for every patient in
the 2 subgroups. This was accomplished by solving the
multivariable hazard function equation twice for each
patient, once for a Norwood procedure pathway and again
for a biventricular repair pathway. The 2 values were then
compared, with the difference representing the benefit in
percent survival at 5 years for the optimal pathway for that
patient on the basis of the characteristics as entered into the
multivariable hazard function models. 
To simplify prediction and to determine additional factors
predictive of optimal pathway and survival benefit, we used
multivariable linear regression analysis to model the differ-
ence in predicted percent survival for the Norwood procedure
over the biventricular repair pathway. Model building strate-
gy was similar to that described above. The final regression
equation could then be solved for an individual patient’s ini-
tial characteristics, with a positive number representing better
predicted survival with the Norwood procedure, a negative
number representing better predicted survival with a biven-
tricular repair strategy, and the magnitude of the number rep-
resenting the degree of predicted survival benefit.
Results
Study population and procedures. A total of 320 eligi-
ble neonates from 24 participating institutions were
entered into the study. Of these, 19 patients either died
before any intervention could be performed or had an
intervention for a reason unrelated to left ventricular
outflow tract obstruction and subsequently died. These
patients were excluded from further analyses. Initial
left ventricular outflow tract intervention indicated an
intended non-biventricular repair pathway. Inter-
ventions included primary cardiac transplantation in 6
Fig 3. Subsequent procedures and mortality for patients who had an initial surgical procedure indicating an intend-
ed biventricular repair pathway. AVR, Aortic valve replacement; BAV, balloon aortic valvotomy; CPC, cavopul-
monary connection; SAV, surgical aortic valvotomy; Yasui, creation of a Damus-Kaye-Stansel type connection with
closure of a ventricular septal defect to incorporate the neoaorta to the left ventricle and a Rastelli-type connection
from the right ventricle to the pulmonary arteries.
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patients, with 1 subsequent death, and a Norwood pro-
cedure in 179 patients, with 64 subsequent deaths. An
initial intended biventricular repair pathway was indi-
cated in 116 patients, with 32 subsequent deaths. Initial
and subsequent interventions for left ventricular out-
flow tract obstruction are shown in flow diagrams for
patients on non-biventricular repair pathways (Fig 1)
and for patients on an initial intended biventricular
repair pathway who had either an initial transcatheter
aortic balloon valvotomy (Fig 2) or an initial surgical
procedure (Fig 3). 
Characteristics by initial intended pathway. Given
the small number of patients who had initial cardiac
transplantation and the fact that cardiac replacement
effectively neutralizes all initial functional and morpho-
logic factors, these patients were excluded from all sub-
sequent analysis, leaving only patients who had an ini-
tial Norwood procedure in the non-biventricular repair
group. Demographic, functional, and morphologic char-
acteristics of patients at initial entry are given in Table I,
divided into 2 groups by initial intended pathway of
either biventricular repair or Norwood procedure. 
Fig 4. Survival after entry for patients who had an initial procedure indicating an intended biventricular repair path-
way (n = 116). The circles represent the Kaplan-Meier estimate for survival at each death, the solid lines represent
the parametric determination of continuous point estimates, and the dashed lines enclose the 70% confidence inter-
val. A, Percent survival; B, hazard function.
A
B
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Multivariable logistic regression analysis was used to
determine independent factors associated with the initial
intended decision to pursue a biventricular versus a
Norwood procedure pathway. Independent factors dis-
criminating an initial decision in favor of a biventricular
repair pathway are shown in Table II and include a high-
er z-score of the aortic valve anulus diameter, a higher
echocardiographic peak instantaneous gradient across
the left ventricular outflow tract, a higher z-score of the
mitral valve anulus diameter, the absence of an aortic
coarctation, and 2 institutions. After controlling for these
factors, no other variable met criteria for entry into the
model. This equation discriminated the 2 groups with a
great deal of accuracy, with an area under the receiver-
operating characteristic curve of 0.947 (P < .001).
Survival with biventricular repair pathway.
Survival for the 116 patients who had an initial interven-
tion indicating a biventricular repair pathway is shown in
Fig 4. Survival was 82% at 1 month after entry, 77% at
3 months, 72% at 1 year, 71% at 2 years, and 70% at 5
years. Incremental risk factors for time-related death
after entry are shown in Table III and include a higher
subjective echocardiographic grade of endocardial fibro-
elastosis, a lower z-score of the aortic valve diameter at
the level of the sinuses of Valsalva, and a younger age at
entry. The effects of each of these significant factors on
time-related death are shown in Figs 5 to 7. 
Because the echocardiographic appearance was a
significant predictor of survival in this group of
patients, we compared the echocardiographic grade
of endocardial fibroelastosis as noted by the indepen-
dent blinded echocardiogram review to the findings
at autopsy in those patients who had died, regardless
of pathway or procedures, using the same criteria for
the grading. Of the 211 patients who had echocardio-
gram review, 69 died, 37 of whom had some endo-
cardial fibroelastosis. Autopsy findings were avail-
able for only 23 of the deaths, and the agreement is
shown in Table IV. In general, agreement was fair,
with a weighted kappa statistic of 0.33 (95% confi-
dence interval, 0.07-0.59), although 2 patients with
extensive endocardial fibroelastosis at autopsy were
believed to have no endocardial fibroelastosis on the
initial echocardiogram.
Survival with Norwood procedure pathway.
Survival for the 179 patients who had an initial Norwood
procedure is shown in Fig 8. Survival was 80% at 1
month after entry, 71% at 3 months, 64% at 1 year, 62%
Table II. Independent factors discriminating patients who had an initial intervention indicating a decision for a
biventricular repair versus a Norwood procedure pathway for critical left ventricular outflow obstruction* (CHSS
1994-2000, n = 294)
Variable Parameter estimate† (SE) Odds ratio (95% CI) P value
Intercept 1.750 (0.776)
Higher z-score of aortic  valve anulus  diameter (per 1 SD increase) 0.361 (0.089) 1.43 (1.21, 1.71) <.001
Higher initial echocardiographic peak instantaneous gradient
across the LV outflow tract (per 10 mm Hg increase) 0.537 (0.116) 1.71 (1.36, 2.15) <.001
Higher z-score of mitral valve anulus diameter (per 1 SD increase) 0.559 (0.136) 1.75 (1.34, 2.28) <.001
Absence of aortic coarctation 1.238 (0.575) 3.45 (1.12, 10.6) .03
Institution E 1.380 (0.625) 3.97 (1.17, 13.5) .03
Institution K 3.372 (0.927) 29.1 (4.74, 17.9) <.001
CI, Confidence interval; LV, left ventricular; SD, standard deviation; SE, standard error. Hosmer and Lemeshow goodness-of-fit test, P = .44. 
*Excludes 19 patients who died with no intervention and 6 patients who had primary cardiac transplantation.
†Adjusted for missing information for peak instantaneous LV outflow tract gradient.
Table III. Incremental risk factors for time-related death for patients who had an initial procedure indicating an
intended biventricular repair pathway
Variable Parameter estimate* (SE) P value
Higher grade of endocardial fibroelastosis† 0.532 (0.234) .02
Lower z-score of aortic valve diameter at the level of the sinuses of Valsalva 0.360 (0.109) <.001
Younger age at entry‡ 1.488 (0.529) .005
*For a single early hazard phase; adjusted for missing information for z-score of the aortic valve at the level of the sinuses of Valsalva.
†Endocardial fibroelastosis was graded subjectively by the echocardiographic appearance of left ventricular endocardial brightness and thickening as follows: 0 =
none; 1 = involvement of papillary muscles only; 2 = papillary muscle with some endocardial surface involvement; 3 = extensive endocardial surface involvement.
‡Entered after inverse transformation.
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at 2 years, and 60% at 5 years. Incremental risk factors
for time-related death after entry are shown in Table V
and include a lower diameter of the ascending aorta and
the presence of moderate or severe tricuspid regurgita-
tion. The effects of each of these significant factors on
time-related death are shown in Figs 9 and 10.
Optimal pathway and survival benefit. By means
of the separate hazard models for initial intended
Fig 5. Risk-adjusted percent survival after entry predicted for a patient who had an initial procedure indicating an
intended biventricular repair pathway (n = 116), stratified by the grade of endocardial fibroelastosis as noted on the
initial echocardiogram. The patient age at entry was set at 2 days, and the z-score of the aortic valve at the level of
the sinuses of Valsalva was set at –3. Lines represent the parametric determination of continuous point estimates of
survival according to grade: grade 0, no endocardial fibroelastosis; grade 1, endocardial fibroelastosis on the mitral
valve papillary muscles only; grade 2, endocardial fibroelastosis on the papillary muscles and some involvement of
the endocardial surface of the left ventricle; and grade 3, extensive endocardial involvement.
Fig 6. Risk-adjusted percent survival after entry predicted for a patient who had an initial procedure indicating an
intended biventricular repair pathway (n = 116), stratified by values of the z-score of the diameter of the aortic valve
measured at the level of the sinuses of Valsalva on the initial echocardiogram. The patient age at entry was set at 2
days, and the grade of endocardial fibroelastosis as noted on the initial echocardiogram was set to 1 or involvement
of the mitral valve papillary muscles only. Lines represent the parametric determination of continuous point esti-
mates of survival.
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biventricular repair and Norwood procedure as
applied to the combined data set, survival at 5 years
after entry was predicted for each patient twice, once
for the biventricular repair pathway and again for the
Norwood procedure. The difference between the 2
numbers represented the predicted percent survival
benefit for that patient on the basis of the character-
istics for the optimal pathway. Independent factors
from multiple linear regression analysis associated
with this survival benefit are shown in Table VI.
Independent factors associated with the difference in
predicted survival favoring Norwood versus biven-
tricular repair include a higher grade of endocardial
fibroelastosis, lower z-score of the aortic valve at the
level of the sinuses of Valsalva, younger age at entry,
larger ascending aorta diameter, the absence of mod-
erate or severe tricuspid regurgitation, and lower z-
score of the left ventricular length. These factors
accounted for 89% of the variation in predicted sur-
vival benefit, indicating excellent fit of the model.
The regression equation can be solved for individ-
ual patients on the basis of their characteristics to
give the predicted survival benefit. When this was
performed for the patients in our study, 60 of the 116
patients (52%) who had an initial procedure indicat-
ing a biventricular repair pathway would have had
better predicted survival at 5 years after a Norwood
procedure, with a mean increase in 5-year survival
Fig 7. Risk-adjusted percent survival after entry predicted for a patient who had an initial procedure indicating an
intended biventricular repair pathway (n = 116), stratified by the patient age at entry or first admission to a CHSS
institution. The z-score of the aortic valve diameter measured at the level of the sinuses of Valsalva was set at –3,
and the grade of endocardial fibroelastosis was set at 1 or involvement of the mitral valve papillary muscles only.
Lines represent the parametric determination of continuous point estimates of survival.
Table IV. Agreement between echocardiogram review and autopsy findings regarding grade of EFE
Grade of EFE from autopsy
0 1 2 3
Grade of EFE from echo review
0 7* 2 0 2
1 6 0 1 0
2 0 0 0 4
3 0 0 0 1
echo, Echocardiogram; EFE, endocardial fibroelastosis. EFE was graded subjectively by the echocardiographic appearance of left ventricular endocardial brightness
and thickening or by autopsy findings as follows: 0 = none; 1 = involvement of papillary muscles only; 2 = papillary muscle with some endocardial surface involve-
ment; 3 = extensive endocardial surface involvement.
*Figures in the body of the table indicate the number of patients with each grade of EFE.
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for these patients of 19% ± 15%. Likewise, 30 of the
179 patients (17%) who had an initial Norwood pro-
cedure would have had better predicted survival at 5
years with a biventricular repair, with a mean
increase in 5-year survival of 15% ± 11%. 
Discussion
Critical aortic stenosis has long been recognized by
morphologists and practitioners as a cause of death in
early infancy. As early as 1910, Carrel5 and Jeger6 inde-
pendently attempted experimentally to place conduits
between the left ventricular apex and the descending
thoracic aorta. In 1955, a direct surgical approach to the
aortic valve with the use of transventricular dilation
was accomplished by Marquis and Logan,7 followed by
Downey8 in 1956. In 1956, the first open surgical
valvotomy with surface cooling and inflow occlusion
was performed.9-11 In 1958, the first report of open
valvotomy with cardiopulmonary bypass was present-
ed by Spencer, Neill, and Bahnson.12 These operations
remained the only therapeutic options until 1983, when
Lababidi13 reported the use of aortic balloon valvoto-
my, followed in 1984 by Lababidi, Wu, and Walls14
reporting on the use of this technique in 23 patients,
including neonates. Numerous authors have since
reported success with balloon valvotomy.15-25
A
B
Fig 8. Survival after entry for patients who had an initial Norwood procedure (n = 179). The circles represent the
Kaplan-Meier estimate for survival at each death, the solid lines represent the parametric determination of continuous
point estimates, and the dashed lines enclose the 70% confidence interval. A, Percent survival; B, hazard function.
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In the early 1980s, Norwood and colleagues26-29 report-
ed successful operations for the management of
hypoplastic left heart syndrome. As outcomes with both
surgical and balloon valvotomy remained marginal, and
as the morphologic variability in the left-sided cardiac
structures in patients with critical left ventricular outflow
tract obstruction became more evident, the idea of aban-
doning a biventricular repair in favor of a single-ventricle
palliation became attractive, but was again associated
with significant mortality. In 1986, Bailey and associ-
ates30 reported on successful orthotopic cardiac trans-
plantation as a management strategy for neonates with
hypoplastic left heart syndrome. This was a strategy that
could easily be applied to neonates with critical aortic
stenosis and other left-sided cardiac abnormalities. In
1987, Yasui and coworkers31 reported successful correc-
tion of critical aortic stenosis, interrupted aortic arch, and
ventricular septal defect in 2 neonates. They used yet
another operative approach that achieved a biventricular
repair by Damus-Kaye-Stansel anastomosis between the
ascending aorta and main pulmonary artery, with a
Rastelli-type intracardiac tunnel and an extracardiac right
ventricle–distal pulmonary artery conduit. Their
approach abandoned the aortic valve and could be used if
a ventricular septal defect was present. 
In the early 1990s, McKay and colleagues32 examined
the morphology of the ventriculoarterial junction in crit-
ical aortic stenosis in 21 patients at autopsy. These
authors found diffuse and complex abnormalities that
would suggest ongoing hemodynamic difficulties even
in those patients who survived infancy. These authors
suggested that early aortic root replacement with a pul-
monary autograft might be the best way of achieving a
biventricular correction. There have since been sporadic
case reports of the pulmonary autograft, or Ross/Konno
approach, performed in early infancy.33-35 Thus, by the
early 1990s at least 6 different options were available
to neonates with critical aortic stenosis, none of which
met with universal success. Reasons for lack of success
were difficult to quantify. 
Table V. Incremental risk factors for time-related death for patients who had an initial Norwood procedure
Variable Parameter estimate* (SE) P value
Lower diameter of the ascending aorta† 0.952 (0.397) .017
Presence of moderate or severe tricuspid regurgitation 0.862 (0.434) .047
SE, Standard error.
*For a single early hazard phase; adjusted for missing information for ascending aorta diameter.
†Entered after logarithmic transformation.
Fig 9. Risk-adjusted percent survival after entry predicted for a patient who had an initial Norwood procedure 
(n = 179), stratified by the diameter of the ascending aorta above the sinotubular junction as measured on the ini-
tial echocardiogram. Moderate or severe tricuspid regurgitation was set as absent. Lines represent the parametric
determination of continuous point estimates of survival.
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Prompted by therapeutic results that remained disap-
pointing, investigators in the 1980s began matching
hemodynamic and other parameters against outcomes in
patients with critical aortic stenosis in an attempt to iden-
tify risk factors. Gundry and Behrendt,36 in a review of 24
patients undergoing aortic valvotomy in the first 6 months
of life, found that a low ejection fraction, high left ven-
tricular end-diastolic pressure, and presence of endocar-
dial fibroelastosis were all predictive of poor outcome.
Hammon and associates37 examined a group of 19
patients undergoing aortic valvotomy in the first 6 months
of life and found that only elevated mean pulmonary
artery pressure and low left ventricular end-diastolic vol-
ume were predictive of poor outcome; left ventricular
peak systolic pressure, left ventricular end-diastolic pres-
sure, systolic aortic valve gradient, left ventricular ejec-
tion fraction, and age at operation were not predictive. 
Rhodes and associates38 examined a group of 65
patients with critical aortic stenosis after they had
undergone a biventricular repair. The anatomic vari-
ables examined by these authors included the follow-
ing: body surface area, indexed left ventricular end-
diastolic volume, indexed left ventricular end-systolic
volume, indexed left ventricular mass, indexed aortic
anulus, indexed aortic root, indexed aortic arch,
indexed aortic isthmus, indexed left ventricular long
axis, relative left ventricular long axis, indexed mitral
valve area, relative mitral valve area, Doppler gradi-
ents, and ejection fractions. These authors found that
the best predictive equation for survival included body
surface area (BSA), aortic root dimension indexed to
body surface area (ROOTI), the ratio of the long-axis
dimension of the left ventricle to the long-axis dimen-
sion of the heart (LAR), and the indexed mitral valve
Fig 10. Risk-adjusted percent survival after entry predicted for a patient who had an initial Norwood procedure 
(n = 179), stratified by the presence or absence of moderate or severe tricuspid regurgitation as noted on the initial
echocardiogram. The diameter of the ascending aorta above the sinotubular junction was set at 4 mm. Lines repre-
sent the parametric determination of continuous point estimates of survival.
Table VI. Independent factors predictive of percent survival benefit at 5 years after entry for Norwood procedure
versus biventricular repair*
Variable Parameter estimate (SE) P value
Intercept –86.47 (6.36)
Higher grade of endocardial fibroelastosis 12.14 (0.96) <.001
Lower z-score of aortic valve at the level of the sinuses of Valsalva –6.20 (0.25) <.001
Younger age at entry (d)† 30.55 (1.79) <.001
Larger ascending aorta diameter (mm)‡ 23.33 (2.24) <.001
Absence of moderate or severe tricuspid regurgitation –28.30 (2.60) <.001
Lower z-score of the LV length –0.70 (0.22) .02
SE, Standard error.
*Adjusted for missing values for all variables; model R2 = 0.888; root mean square error = 9.858.
†Inverse of (age at entry + 1) transformation.
‡Logarithmic transformation.
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area (MVAI). The equation for the discriminating score
for survival was as follows: Score = 14.0 (BSA) +
0.943 (ROOTI) + 4.78 (LAR) + 0.157 (MVAI) – 12.3,
with a discriminating score of less than –0.35 predic-
tive of death after a 2-ventricle repair. The equation
was found to have a predictive value of 88% to 91%
when applied to their own patient group. For the next
several years, several investigators attempted to assess
the performance of the Rhodes score in predicting sur-
vival in other patient groups.39-41 The results of these
efforts are summarized in Table VII.
Other authors have examined whether biventricular
repair can be accomplished in ductus-dependent
neonates with multiple levels of left ventricular outflow
tract obstruction and hypoplastic but morphologically
normal left ventricles.42,43 Both series reported a high
incidence of reoperation even if a successful biventric-
ular repair could be accomplished. Thus, there exists no
unanimity of opinion regarding what combination of
left-sided structures will be adequate to perform a
biventricular correction and how that adequacy can be
accurately assessed before embarking on 1 of 6 thera-
peutic pathways. Indeed, one group of authors has even
advocated the continued use of transventricular dilation
for critical aortic stenosis in neonates, thus further
clouding an already murky picture.44
Each of the previous studies involved small numbers
of patients, a fact that helps to account for the variabil-
ity between studies as to which demographic, hemody-
namic, and morphometric factors were important in
predicting outcomes after 2-ventricle versus 1-ventricle
repair for patients with critical aortic stenosis. The 
present study involves a patient group that is greater in
number than the total number for all other studies com-
bined and examines as independent variables all of the
parameters investigated by all of the other authors. Thus,
innumerable independent variables were examined for
each of the 320 patients. The large patient cohort enabled
multiple logistic regression which determined features
that discriminated between patients selected for biven-
tricular repair versus Norwood pathways. Parametric
modeling of survival and hazard of time-related death
was performed separately for the biventricular and
Norwood patients, and independent risk factors for time-
related death were determined from these 2 hazard mod-
els. A prediction of survival at 5 years could be calculat-
ed for all patients. Indeed, for each patient, predicted
survival for the biventricular repair versus the Norwood
pathway was compared, with the difference representing
the predicted survival benefit. Multiple linear regression
analysis was then performed to identify independent fac-
tors associated with the survival benefit. The final result
was a multiple linear regression equation that predicted
both the magnitude and the direction of the survival ben-
efit for the optimal pathway. The regression equation can
be solved for characteristics of an individual patient to
give the predicted 5-year survival benefit of Norwood
versus biventricular repair as follows:
Survival benefit = Intercept + b1 (age at entry) 
+ b2 (z-score of aortic valve at the sinuses) + b3
(grade of EFE) + b4 (ascending aorta diameter) + b5
(presence of moderate or severe tricuspid regurgita-
tion) + b6 (z-score of the left ventricular length)
with the appropriate transformations and parameter
estimates as given in Table VI. The 70% confidence
interval can be calculated by adding and subtracting the
root mean square error from the predicted survival ben-
Table VII. Previous studies of risk factors for mortality in neonates with critical left ventricular outflow 
obstruction, small left ventricles, or both
Study No. of patients Type of patients Significant risk factors for mortality Comments
Rhodes et al 65 Neonates and infants, BSA, indexed aortic root, ratio of LV to Patients preselected for biventricular 
(1991) critical aortic stenosis heart length, indexed mitral  valve area repair, all had valvotomy
Parsons et al 25 <3 months, Age, mitral valve diameter, LV  LV cross-sectional area <2 cm2 is a 
(1991) aortic valvotomy end-diastolic dimension, left atrial risk factor for perioperative death 
dimension and cross-sectional area,
LV end-diastolic volume
Kovalchin et al 28 Neonates, critical Indexed aortic anulus, aortic root, Echocardiographic determination of
(1997) aortic stenosis ascending aorta, LV long-axis morphology and direction of aortic
length, direction flow ascending and 
transverse aorta
Tani et al 20 Neonates, aortic Retrospective review of 20 neonates  
(1999) arch obstruction, with a Rhodes score that would 
coarctation, no critical have precluded biventricular
aortic stenosis repair—undergoing successful
biventricular repair
BSA, Body surface area; LV, left ventricular.
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efit. The result gives the predicted difference in percent
survival for Norwood minus biventricular repair. A pos-
itive number would therefore favor a Norwood proce-
dure and a negative number would favor a biventricular
repair, with the magnitude of the number representing
the predicted difference in percent survival or the sur-
vival benefit for the optimal pathway.
An example of how the multiple linear regression
equation can be used to predict optimal pathway and
survival benefit is demonstrated for individual patients
in Figs 11 and 12. 
From this study, 4 conclusions might be drawn. First,
mortality is high for critical left ventricular outflow
tract obstruction in neonates. Second, survival may be
improved by more appropriate selection of repair path-
ways. Third, risk factors for mortality differ for
Norwood versus biventricular repair pathways. Finally,
the pathways predicting survival benefit from Norwood
versus biventricular repair relate to the adequacy of
left-sided structures.
We may also make several inferences from our find-
ings. First, the use of a multivariable equation from these
data would improve patient selection for Norwood or
biventricular repair and overall survival in neonates with
critical left ventricular outflow obstruction. Second,
without the use of the equation, there is a significant
error rate for each pathway, with 50% of the biventricu-
lar repair patients having better predicted survival with a
Norwood approach and 20% of the Norwood patients
having better predicted survival with biventricular repair.
Third, the present study is limited in that we cannot yet
examine late problems that might be anticipated to occur
in both groups of patients. Patients undergoing biven-
tricular repair experience ongoing problems with the left
ventricular outflow tract and future problems related to
the mitral valve and aortic arch. Likewise, the single-
ventricle pathway patients may yet experience problems
associated with aging and single-ventricle physiology.
Fourth, the role of the Ross procedure in patients for
whom a biventricular repair pathway is undertaken could
not be determined by this study. Last, the role of prima-
ry cardiac transplantation could not be evaluated. There
may be a selected group of patients on both the biven-
tricular repair and the Norwood pathways for whom sur-
vival with either approach would be so poor that prima-
ry cardiac transplantation may offer the only viable
approach. It is likely that patients who have a very small
ascending aorta may fall into this category.
Along with members of the CHSS, we strongly
encourage the prospective use of this multiple variable
equation in determining management strategies with
neonates with critical aortic stenosis. The multiple
Fig 11. Risk-adjusted percent survival after entry predicted for both an initial intended biventricular repair and a
Norwood procedure pathway for a study patient who had an initial Norwood procedure and survived. The patient’s
characteristics were as follows: age at entry, 8 days, z-score of the aortic valve at the level of the sinuses of Valsalva,
–3.2 (7.6 mm); grade of endocardial fibroelastosis, 0 or absent; diameter of the ascending aorta, 9.4 mm; moderate
or severe tricuspid regurgitation, absent; and z-score of the left ventricular length, –2.2. The solid lines represent the
parametric determination of continuous point estimates of survival, with the dashed lines enclosing the 70% confi-
dence interval. The predicted survival at 5 years after entry for this patient would be 78% for a Norwood procedure
pathway and 91% for a biventricular repair pathway. The predicted survival benefit from the multiple linear regres-
sion equation would be +9.7% in favor of biventricular repair pathway (70% confidence interval, –0.1% to +19.6%). 
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variable equation will be posted on the Web site of the
CHSS, along with a built-in calculator. The CHSS Web
site can be accessed at www.chssdc.org.
We acknowledge the assistance of the personnel at the
Congenital Heart Surgeons Society Data Center, especially
Geraldine Cullen-Dean and Jay Joseph, in the analysis of
these data and preparation of the manuscript. We also
acknowledge the advice and assistance of Jeffrey F.
Smallhorn, MD, in echocardiographic interpretation. 
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Discussion
Dr Frank L. Hanley (San Francisco, Calif). This project is
an impressive undertaking. I congratulate the authors for their
work. 
This study contains a great deal of information, so it is par-
ticularly important to distill this information down to the
essentials. First, it is important to understand that left ven-
tricular outflow tract obstruction in the neonate is a morpho-
logic and physiologic spectrum. The surgeon, however, must
make a dichotomous decision with respect to treatment: 2-
ventricle repair or Norwood. The study population comprises
2 large groups, those treated with a Norwood procedure and
those treated with so-called 2-ventricular repair, which, in
essence, is aortic valvotomy; 111 of 116 patients had aortic
valvotomy in that second group. 
Using the statistical methods described, the study exam-
ines outcomes and incremental risk factors for time-related
death for each group, Norwood and aortic valvotomy. The
eventual model, as represented by the multivariable hazard
function equation, can then be solved twice for each indi-
vidual, as shown in several examples, once for the
Norwood and once for the 2-ventricle, or aortic valvotomy,
repair. The 2 values can then be compared to determine the
optimal treatment for each individual patient. 
Specifically looking at the patients who underwent aortic
valvotomy, the analysis shows that death is increasingly more
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likely in patients with smaller aortic valves and in the presence
of endocardial fibroelastosis. This makes perfect sense. Aortic
valvotomy does not address either of these morphologic
issues, so it is not surprising that attempting an aortic valvoto-
my in the face of increasingly small aortic valves and increas-
ing endocardial fibroelastosis will be completely ineffective. It
would not be too dramatic to say that aortic valvotomy in this
setting is a completely irrational treatment option. 
When the predicted mortality for a given patient becomes
higher with aortic valvotomy than with a Norwood proce-
dure, this study suggests that the Norwood operation should
be the treatment of choice. This is somewhat logical and
makes a certain amount of intuitive sense until one includes
the reality that survival for the average Norwood operation is
62% at 2 years. It is difficult to be enthusiastic about choos-
ing an alternative operation for any individual patient when
that alternative offers only a 62% survival at 2 years. 
As such, the analysis could not be a better advertisement
for recommending the pulmonary autograft as the procedure
of choice for patients with many forms of critical neonatal
left ventricular outflow tract obstruction. The Ross procedure
normalizes the left ventricular outflow tract dimensions and
hemodynamics and allows easy access to the left ventricular
myocardium for resection of endocardial fibroelastosis. This
not only gets rid of the endocardial fibroelastosis but actual-
ly lengthens the long dimension of the left ventricle, another
risk factor identified in this study. Therefore, it directly
addresses the two most important morphologic risk factors
for death with an attempted 2-ventricle repair. 
According to the analysis represented by the models in this
study, for an individual patient with an aortic valve z-value of
zero and absence of endocardial fibroelastosis, the 5-year sur-
vival is greater than 95%. Unfortunately, not many neonates
with critical left ventricular outflow obstruction have these
favorable morphologic characteristics. The Ross, or Ross-
Konno, if necessary, or Ross-Konno with endocardial fibro-
elastosis resection can reassign many of the high-risk patients
with critical left ventricular outflow tract obstruction into
patients with normal aortic valve diameter and no endocardial
fibroelastosis. The models in this study could then predict a
95% 5-year survival. My own experience with the Ross oper-
ation in this very same setting would substantiate that kind of
5-year outcome. Such an outcome is clearly superior to
valvotomy and is also clearly superior to the alternative, the
Norwood operation, with a 60% 2-year survival. 
I have 2 specific questions; both relate somewhat more to
the manuscript than to the presentation. The manuscript men-
tions that patients were entered into the study up until
February 2000. The manuscript also mentions that follow-up
was completed in September 1999. Now, either that is a typo-
graphical error or the patients entered after September 1999
were somehow treated in a different manner with less or dif-
ferent or no follow-up. This issue should be clarified.
The second point relates to the method, with respect to
the analysis of the endocardial fibroelastosis. The study of
the autopsy series shows relatively poor correlation
between the echocardiographic diagnosis of endocardial
fibroelastosis, which was used in the analysis, and a few
patients in whom autopsy evidence of endocardial fibro-
elastosis was shown. The 2 methods agreed on the exact
degree of endocardial fibroelastosis in only 8 of 23 patients
tested. 
It seems that the echocardiogram underestimated the spec-
trum of endocardial fibroelastosis; in other words, it underes-
timated both the absent endocardial fibroelastosis and the
very severe endocardial fibroelastosis. I would be interested
in your comments on this lack of correlation and how you
think the echocardiographic diagnosis narrowing the spec-
trum of endocardial fibroelastosis may have implications for
your multivariable analysis. 
Dr Lofland. Thank you for your kind comments, Dr
Hanley. We share the observations you have expressed about
the utility of the Ross procedure or the pulmonary autograft.
This study was truly a collaborative effort in the finest sense
of the word, and we are still actively enrolling patients in the
study, which helps to explain a little bit of the discrepancy in
follow-up terminology. 
Regarding the grading of endocardial fibroelastosis, we
attempted in this study to examine every variable that every
other author has ever proposed as a risk factor for patients
with critical aortic stenosis or critical left ventricular outflow
tract obstruction. Granted there will be discrepancy between
echocardiographic grading of endocardial fibroelastosis and
grading at autopsy. We went with echocardiographic grading
because that is the grading method that will be used in clini-
cal decision-making for these patients. 
Appendix A. Morphologic and functional characteristics measured and calculated from the independent blinded
review of the initial echocardiogram reading
Variable name Echo view Comment
Right atrium, tricuspid valve
Right atrial area (cm2) SC Traced endocardial surface
Size of ASD or PFO (mm) SC
Flow characteristics across ASD or PFO SC From color flow Doppler
Gradient across ASD or PFO (mm Hg) SC From pulsed Doppler
Tricuspid valve AP diameter (mm) PSLA Measured between hinge points at anulus
Tricuspid valve lateral diameter (mm) AP4C Measured between hinge points at anulus
Grade of tricuspid regurgitation AP4C, PSSA From color flow Doppler
Tricuspid regurgitation gradient (mm Hg) AP4C From pulsed and continuous wave Doppler
Continued.
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Appendix A. Cont’d
Variable name Echo view Comment
Ventricular septum
Presence and characteristics of VSD All views VSD number, size, location
Gradient across VSD (mm Hg) All views From pulsed and continuous wave Doppler
Left atrium, mitral valve
Left atrial area (cm2) SC Traced from endocardial surface
Mitral valve AP diameter (mm) PSLA Measured between hinge points at anulus
Mitral valve lateral diameter (mm) AP4C Measured between hinge points at anulus
Grade of mitral regurgitation AP4C, PSLA From color flow Doppler
Mitral regurgitation jet width (mm) AP4C Diameter of color flow Doppler jet at anulus
Characteristics, gradient of mitral obstruction AP4C, PSLA Level of obstruction (annular, subvalvular or supravalvular),
Doppler gradient
Mitral valve structural anomalies PSSA Parachute mitral valve, thickening and mobility of leaflets, papillary 
muscle position
Left ventricle
Long-axis endocardial length of LV (mm) AP4C, diastole Measured from mitral valve anulus level to endocardium of LV apex
Long-axis epicardial length of LV (mm) AP4C, diastole Measured from mitral valve anulus level to epicardium of LV apex
Long-axis endocardial of heart (mm) AP4C, diastole Measured from crux of heart to endocardium to apex
Long-axis endocardial length of LV (mm) AP4C, systole Measured from mitral valve anulus level to endocardium of LV 
apex
Short-axis LV endocardial area (cm2) PSSA, diastole Traced from endocardial surface at midventricular level
Short-axis LV epicardial area (cm2) PSSA, diastole Trace from epicardial surface at midventricular level
Short-axis LV endocardial area (cm2) PSSA, systole Traced from endocardial surface at midventricular level
Presence/grade of endocardial fibroelastosis All views Mild—involves only papillary muscle area
Moderate—papillary muscle and some part of LV endocardium
Severe—extensive endocardial involvement
Subaortic region, aortic valve 
Type of obstruction of subaortic region All views Fibromuscular ridge, tunnel, chordae, or other mechanism
Smallest diameter of subaortic area (mm) PSLA, systole From endocardial surface
Gradient across LV outflow tract (mm Hg) AP5C, SSN From pulsed and continuous wave Doppler, peak instantaneous and 
mean gradient 
Aortic valve characteristics All views Number of cusps, mobility, thickening 
Grade of aortic regurgitation PSLA From color Doppler
Aortic regurgitation jet width (mm) PSLA Diameter of color flow Doppler jet at anulus
Aortic valve anulus (mm) PSLA Measured between hinge points at anulus
Aortic root (sinus of Valsalva) diameter (mm) PSLA Measured at maximal dimension, inner surface
Sinotubular junction diameter (mm) PSLA Measured at maximal dimension, inner surface
Ascending aorta, aortic arch
Ascending aorta (mm) PSLA Measured at level above sinotubular junction
Distal transverse aortic arch (mm) SSN Measured between LCC and LSCA
Aortic isthmus (mm) SSN Measured distal to LSCA
Descending aorta (mm) SC Measured at level of diaphragm
Flow characteristics at ascending aorta SSN Predominant antegrade or retrograde flow from pulsed and color 
flow Doppler
Flow characteristics at transverse aortic arch SSN Predominant antegrade or retrograde flow fromm pulsed and color 
flow Doppler
Aortic coarctation diameter (mm) SSN Narrowest dimension




LV long-axis ratio to heart
LV end-systolic and end-diastolic volumes
Ejection fraction calculated from diameters and volumes
Ratio of regurgitant jet width to anulus width
Mitral and tricuspid valve areas
Ratio of mitral valve area to sum of mitral and tricuspid valve areas
Many variables were also indexed to body surface area or converted to z-scores.
Echocardiogram views: AP4C, Apical 4-chamber; AP5C, apical 5-chamber; PSLA, parasternal long axis; PSSA, parasternal short axis; SC, subcostal; SSN, supraster-
nal notch. AP, Anteroposterior; ASD, atrial septal defect; LLC, left common carotid; LSCA, left subclavian artery; LV, left ventricle (ventricular); PFO, patent fora-
men ovale; VSD, ventricular septal defect.
